Olarn Roengvoraphoj

4PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 08, 2018
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.

Olarn Roengvoraphoj, Chukwuka Eze, Cherylina Wijaya

|Mar 16, 2018
Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.

Olarn Roengvoraphoj, Cherylina Wijaya, Chukwuka Eze

|Nov 09, 2017
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.

Olarn Roengvoraphoj, Cherylina Wijaya, Chukwuka Eze

|Nov 18, 2016
Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.

Olarn Roengvoraphoj, Chukwuka Eze, Maximilian Niyazi

Pageof 1

Frequent Collaborators